FDA Approves First RSV Drug to Protect All Infants From Virus
While the infection often leads to mild, coldlike symptoms, it is the leading cause of hospitalization of infants in the U.S.
Parents have a new tool to protect their newborns from a common but potentially deadly respiratory virus that sends tens of thousands of babies to the hospital each year.